BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8422744)

  • 1. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
    Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
    Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA; Grimes DA; Lopez LM; Schulz KF; Helmerhorst FM
    Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD003553. PubMed ID: 22071807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive sales in the setting of the Zika virus epidemic.
    Bahamondes L; Ali M; Monteiro I; Fernandes A
    Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
    Nappi RE; Paoletti AM; Volpe A; Chiovato L; Howard B; Weiss H; Ricciotti N
    Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):285-94. PubMed ID: 24923685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.
    Palacios S; Colli E; Regidor PA
    Arch Gynecol Obstet; 2019 Dec; 300(6):1805-1812. PubMed ID: 31728664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
    Etminan M; Delaney JA; Bressler B; Brophy JM
    CMAJ; 2011 May; 183(8):899-904. PubMed ID: 21502354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.
    Palacios S; Colli E; Regidor PA
    PLoS One; 2020; 15(6):e0231856. PubMed ID: 32598387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Cameron ST; Glasier A; McDaid L; Radley A; Baraitser P; Stephenson J; Gilson R; Battison C; Cowle K; Forrest M; Goulao B; Johnstone A; Morelli A; Patterson S; McDonald A; Vadiveloo T; Norrie J
    Lancet; 2020 Nov; 396(10262):1585-1594. PubMed ID: 33189179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults.
    Lin S; Ionescu A; Maynard-Scott J; Kennedy M; Walling DP; Furey M; Singh JB
    Clin Transl Sci; 2024 May; 17(5):e13791. PubMed ID: 38700236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system.
    Plagianos MG; Ramanadhan S; Merkatz RB; Brache V; Friedland BA; Haddad LB
    Am J Obstet Gynecol; 2024 May; 230(5):548.e1-548.e8. PubMed ID: 38295968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users.
    Jensen JT; Archer DF; Westhoff CL; Nelson AL; Graham S; Bernick B
    J Womens Health (Larchmt); 2023 Jul; 32(7):808-815. PubMed ID: 37253139
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive.
    Zhao Y; Versavel M; Tidemann-Miller B; Christmann R; Naik H
    Clin Drug Investig; 2020 Aug; 40(8):737-746. PubMed ID: 32564301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study.
    Shurie S; Were E; Orang'o O; Keter A
    Pan Afr Med J; 2018; 31():214. PubMed ID: 31447973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
    Palacios S; Colli E; Regidor PA
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1549-1557. PubMed ID: 31321765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study.
    Gawron LM; Sexsmith CD; Carter G; Kaiser JE; Pangasa M; Turok DK
    Contraception; 2024 Mar; 131():110344. PubMed ID: 38008305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Oral Tranexamic Acid Versus Combined Oral Contraceptives for Heavy Menstrual Bleeding.
    Rahman S; Khan FS; Samin KA; Afridi N; Ahmed M
    Cureus; 2021 Oct; 13(10):e19122. PubMed ID: 34858760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
    Dragoman M; Petrie K; Torgal A; Thomas T; Cremers S; Westhoff CL
    Contraception; 2013 Apr; 87(4):432-6. PubMed ID: 23312933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study.
    Mercier AK; Kois AK; Karsanji D; Baldry R; Birve F; Hedwall M; Molodetskyi O; Gillen M
    Clin Pharmacol Ther; 2024 Apr; ():. PubMed ID: 38686600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of estriol in inhibiting epithelial proliferation in mammary fibroadenoma: randomized clinical trial.
    Estevão RA; Baracat EC; Logullo AF; Oshima CT; Nazário AC
    Sao Paulo Med J; 2007 Nov; 125(6):343-50. PubMed ID: 18317605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.